NPS MedicineWise denies selling 'its soul to big pharma'

NPS MedicineWise has written to doctors declaring it has not “sold its soul to big pharma” after it emerged it was delivering GP medical education in return for drug company cash.

In a lengthy email message on Wednesday, the organisation's CEO Dr Lynn Weekes (PhD) (pictured) defended its decision to set up a commercial subsidiary VentureWise, which has been paid $214,000 by GSK to educate GPs on COPD and asthma.

VentureWise is also selling commercial clients access to the NPS MedicineInsight program, which produces